GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Big Pharma Split Corp (TSX:PRM) » Definitions » Scaled Net Operating Assets

Big Pharma Split (TSX:PRM) Scaled Net Operating Assets : 0.54 (As of Jun. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Big Pharma Split Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Big Pharma Split's operating assets for the quarter that ended in Jun. 2024 was C$26.06 Mil. Big Pharma Split's operating liabilities for the quarter that ended in Jun. 2024 was C$11.83 Mil. Big Pharma Split's Total Assets for the quarter that ended in Dec. 2023 was C$26.54 Mil. Therefore, Big Pharma Split's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2024 was 0.54.

Big Pharma Split Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Big Pharma Split's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(26.331-10.684)/39.096
=0.40

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Balance Sheet Cash And Cash Equivalents
=26.535 - 0.204
=26.331

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=10.684 - 0 - 0
=10.684

Big Pharma Split's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Jun. 2024 )
=(Operating Assets (Q: Jun. 2024 )-Operating Liabilities (Q: Jun. 2024 ))/Total Assets (Q: Dec. 2023 )
=(26.056-11.828)/26.535
=0.54

where

Operating Assets(Q: Jun. 2024 )
=Total Assets - Balance Sheet Cash And Cash Equivalents
=27.649 - 1.593
=26.056

Operating Liabilities(Q: Jun. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=11.828 - 0 - 0
=11.828

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Big Pharma Split Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Big Pharma Split's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Big Pharma Split Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Big Pharma Split Corp (TSX:PRM) » Definitions » Scaled Net Operating Assets
Comparable Companies
TSX:PWI TSXV:MONT TSX:XTD TSX:MDS.UN TSXV:FW TSXV:TORR TSX:MSRE.UN XCNQ:IDK TSXV:TIE XCNQ:SPLY BLK BX OSTO:INVE A TSX:BN KKR APO BK AMP XSWX:PGHN LSE:III
Traded in Other Exchanges
XN4:Germany PRM.PR.A.PFD:Canada
Address
610 Chartwell Road, Suite 204, Oakville, ON, CAN, L6J 4A5
Website
https://www.harvestportfolios.com
Big Pharma Split Corp is a mutual fund corporation. Its investment objective is to provide shareholders with fixed cumulative preferential quarterly cash distributions, and regular monthly cash distributions. The company has a presence in the United States; Switzerland; France and United Kingdom.
Executives
Michael Kovacs Director, Senior Officer